Comprehensive Genomic Profiling: A Required Tool for Precision Oncology
Two studies presented at ASCO23 demonstrate the critical importance of access to comprehensive genomic profiling in patients with NSCLC and mCRC (Abstracts 3602 and 6506).
Two studies presented at ASCO23 demonstrate the critical importance of access to comprehensive genomic profiling in patients with NSCLC and mCRC (Abstracts 3602 and 6506).
Use of screening logs to document enrollment barriers at the local level can facilitate development of strategies to enhance accrual.
REGISTER The American Cancer Society recently shared a bleak figure – for the first time, new cases of cancer in the United States are expected…
The OncoAlert Newsletter is now out for June 23-29, 2023
The Investor Relations website contains information about Merus’s business for stockholders, potential investors, and financial analysts.
Pourquoi nos bras ne repoussent-ils pas ? Faut-il faire baisser la fièvre ? Comment savoir si un traitement fonctionne ? Les labos inventent-ils les maladies…
We’re a community seeking to improve prioritization, collaboration, reproducibility, and funding of scientific research. Discuss and discover academic research on ResearchHub
The UK’s approach to tackling income inequality in the UK may be harming as much as it helps by subsidising profits while workers are stuck…
Subcutaneous atezolizumab is approved for the treatment of various solid tumors. Previous results from the IMscin001 study (NCT03735121) demonstrated that the pharmacokinetics, efficacy, immunogenicity, and…
Musk has recommended people experiencing severe neck and back pain should consider disc replacement surgery. Here’s what the research says.